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ABSTRACT
Objective To assess the relation between the level of
habitual salt intake and stroke or total cardiovascular
disease outcome.
Design Systematic review and meta-analysis of
prospective studies published 1966-2008.
DatasourcesMedline(1966-2008),Embase(from1988),
AMED (from 1985), CINAHL (from 1982), Psychinfo (from
1985), and the Cochrane Library.
Review methods For each study, relative risks and 95%
confidence intervals were extracted and pooled with a
random effect model, weighting for the inverse of the
variance. Heterogeneity, publication bias, subgroup, and
meta-regression analyses were performed. Criteria for
inclusion were prospective adult population study,
assessment of salt intake as baseline exposure,
assessment of either stroke or total cardiovascular
disease as outcome, follow-up of at least three years,
indicationofnumberofparticipantsexposedandnumber
of events across different salt intake categories.
Results There were 19 independent cohort samples from
13 studies, with 177025 participants (follow-up 3.
5-19 years) and over 11000 vascular events. Higher salt
intake was associated with greater risk of stroke (pooled
relative risk 1.23, 95% confidence interval 1.06 to 1.43;
P=0.007) andcardiovasculardisease(1.14,0.99to1.32;
P=0.07), with no significant evidence of publication bias.
For cardiovascular disease, sensitivity analysis showed
that the exclusion of a single study led to a pooled
estimate of 1.17 (1.02 to 1.34; P=0.02). The associations
observed were greater the larger the difference in sodium
intake and the longer the follow-up.
Conclusions High salt intake is associated with
significantly increased risk of stroke and total
cardiovascular disease. Because of imprecision in
measurementofsaltintake,theseeffectsizesarelikelyto
be underestimated. These results support the role of a
substantial population reduction in salt intake for the
prevention of cardiovascular disease.
INTRODUCTION
During the past century, the evidence for the risks
imposed on human health by excess salt consumption
has become compelling. The causal relation between
habitual dietary salt intake and blood pressure has
been establishedthrough experimental, epidemiologi-
cal, migration, and intervention studies. Most adult
populations around the world have average daily salt
intakeshigherthan6g,andformanyineasternEurope
andAsiahigherthan12g.Internationalrecommenda-
tionssuggestthataveragepopulationsaltintakeshould
be less than 5-6 g per day. Population based inter-
vention studies and randomised controlled clinical
trials have shown that it is possible to achieve signifi-
cant reductions in blood pressure with reduced salt
intake in people with and without hypertension.
1
Based on the effects of high salt intake on blood pres-
sure and on the prominent role of high blood pressure
in promoting cardiovascular diseases, it has been sug-
gested that a population-wide reduction in salt intake
could substantially reduce the incidence of cardio-
vascular disease.
2 On the basis of the results of a
meta-analysis of randomised controlled trials of salt
reduction,
3itwasestimatedthatareductioninhabitual
dietarysaltintakeof6gadaywouldbeassociatedwith
reductions in systolic/diastolic blood pressure of
7/4 mm Hg in people with hypertension and 4/2 mm
Hg in those without hypertension. At the population
level these reductions in blood pressure could predict
an average lower rate of 24% for stroke and 18% for
coronary heart disease.
4 Validation of these predic-
tions by a randomised controlled trial of the effects of
long term reduction in dietary salt on morbidity and
mortality from cardiovascular disease would provide
definite proof. At present, a study of this kind is not
available and, in fact, it is extremely unlikely that it
willeverbeperformedbecauseofpracticaldifficulties,
the long duration required, and high costs. Neverthe-
less, prospective cohort studies performed in the past
three decades that measured the levels of dietary salt
intakeatbaselineand recordedtheincidenceofvascu-
lar events have provided important indirect evidence.
Most of these studies found evidence of such relation,
althoughfewhadenoughpowertoattainstatisticalsig-
nificance.
We performed a systematic review and meta-analy-
sis of the prospective studies of habitual dietary salt
intakeandincidenceofstrokeandtotalcardiovascular
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sionorexclusion.Weassessedwhetherornottheover-
all evidence in prospective studies supports the
presence of a relation between levels of dietary salt
intake and both stroke and cardiovascular outcomes
and calculated an estimate of the risk.
METHODS
Data sources and searches
We performed a systematic search for publications
using Medline (1966-2008), Embase (from 1988),
AMED (from1985), CINAHL(from 1982), Psychinfo
(from 1985), and the Cochrane Library. Search strate-
gies used subject headings and key words with no lan-
guage restrictions. Further information was retrieved
through a manual search of references from recent
reviews and relevant published original studies. We
examined reference lists of the relevant reviews, iden-
tified studies, and reviewed the cited literature.
5
Study selection
Two reviewers (LD and N-BK) independently extra-
cted the data. Discrepancies about inclusion of studies
and interpretation of data were resolvedby arbitration
(PS or FPC), and consensus was reached after discus-
sion.Inthecaseofmissingdata forpotentiallysuitable
studies, we contacted authors and asked them to pro-
vide the necessary information. To be included in the
meta-analysis a published study had to be an original
article published from January 1966 to December
2008, be a prospective population study, assess salt
intake as baseline exposure, determine either stroke
ortotalcardiovasculardiseaseprospectivelyastheout-
come, follow participants for at least three years,
include an adult population, and indicate the number
of participants exposed and the rate or number of
events in different categories of salt intake.
Of the 3246 publications retrieved, we identified 15
studiesthatmettheinclusioncriteria.Onewasadupli-
cateanalysisofasinglecohortpreviouslydescribedby
the same authors
67and another
8 referred to the same
cohort (national health and nutrition examination sur-
vey(NHANES)I)analysedbyotherauthorswithmore
stringent criteria.
9 We therefore included 13 studies in
the meta-analysis that provided suitable data on 19
population samples
610-21 (tables 1 and 2).
Data extraction
From the identified studies and respective populations
we recorded publication reference, total number of
participants, country, sex, age (mean, median, or
range), recruitment time, follow-up (years), outcome
reported (stroke, cardiovascular disease) and method
of outcome assessment, number (rate) of events,
method of assessing salt intake, and level of salt intake
in different categories.
Categorisation of salt intake differed among studies.
Somereportedthenumberofsubjectsexposedandthe
rate (number) of events across the distribution of salt
intake;others reporteddifferences in the eventrate for
a 100 mmol/day difference in sodium intake, as in the
studies by He et al
9 and Tuomilehto et al.
13 In the last
two cases we used the relative risk or hazard ratio
reported by the authors for the analysis. In all the
cases in which categorisation of the study participants
by level of salt intake was available, we calculated the
relative risk of higher versus lower salt intake by com-
paringtheeventrateinthetwocategorieswithadiffer-
ence in average salt intake closest to 100 mmol of
sodium or about 6 g of salt a day.
Statistical analysis
We evaluated the quality of the studies included in the
meta-analysis with the Downs and Black score
system.
21 We extracted relative risks or hazard ratios
from the selected publications and calculated their
standard errors from the respective confidence inter-
vals.Thevaluefromeachstudyandthecorresponding
standard error were transformed into their natural
logarithms to stabilise the variances and to normalise
their distribution. The pooled relative risk (and 95%
confidence interval) was estimated with a random
effect model, weighting for the inverse of the
variance.
22 The heterogeneity among studies was
testedby Qstatisticand quantified byH statisticand I
2
statistic.
23 The influence of individual studies, from
which the meta-analysis estimates are derived, was
examined by omitting one study at a time to see the
extent to which inferences depend on a particular
study or group of studies (sensitivity analysis). Sub-
group or meta-regression analyses were used to iden-
tify associations between risk of stroke or
cardiovascular disease and relevant study characteris-
tics (age and sex of participants, year of publication,
durationoffollow-up,methodofassessmentofsodium
intake, difference in sodium level, control for baseline
blood pressure) as possible sources of heterogeneity.
We used funnel plot asymmetry to detect publication
biasandappliedEgger’sregressiontesttomeasureany
asymmetry.
2425 All statistical analyses were performed
with MIX software version 1.7
26 and Stata software for
meta-regression analysis.
RESULTS
Characteristics of the study cohorts
We included in the meta-analysis 13 studies reporting
on 19 independent cohorts (table 1). There were
177025 participants from six different countries (six
studies from the United States, two each from Finland
and Japan, one each from the Netherlands, Scotland,
and Taiwan). Eleven studies recruited both male and
female participants, while two studies included only
men. Follow-up ranged from 3.5 to 19 years. Four stu-
diesreportedonlystrokeevents(eithertotalstrokerate
or stroke deaths), three only cardiovascular disease
(totalcardiovasculardiseaserateorcardiovasculardis-
ease deaths), and six reported both. Salt intake was
assessed by 24 hour dietary recall (n=4), food fre-
quency questionnaire (n=4), 24 hour urine excretion
(n=4), and questionnaire (n=1). In total there were
5346 strokes reported and 5161 total cardiovascular
disease events. Of the 11 studies that included both
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separately.
6913-15TheTOHPstudyincludedtwodiffer-
ent cohorts (I and II)
17 and the study by He and cow-
orkersprovidedseparate findings formen and women
or, alternatively, for normal weight and overweight
participants.
9 Overall, data on the relation between
salt consumption and stroke were available from 14
cohorts and on the relation between salt intake and
cardiovascular disease from 14 cohorts.
The overall study quality, evaluated by the Downs
andBlackscore,averaged15.5(range12-18)onascale
of 19 (table 1).
Salt intake and risk of stroke
Table 2 provides data on the relation between salt
intake and risk of stroke in each of the 14 cohorts
included in our study. Figure 1 shows the results of
the pooled analysis. In the pooled analysis, higher salt
intake was associated with greater risk of stroke (rela-
tive risk 1.23, 95% confidence interval 1.06 to 1.43;
P=0.007).Therewassignificantheterogeneitybetween
studies(P=0.04;I
2=61%).Thefunnelplotdidnotshow
asymmetry, thus excluding publication bias (Egger’s
test P=0.26; see appendix on bmj.com). As shown in
figure 1 for the individual cohorts included in the ana-
lysis, we found a trend towards a direct association
between salt intake and risk of stroke in nine cohorts,
which was significant in four. We observed a non-sig-
nificant inverse trend in three cohorts.
Sensitivity analysis showed that the pooled estimate
of the effect of salt intake on risk of stroke did not vary
substantially with the exclusion of any one study; in
particular, the exclusion of the study by Umesawa et
al,
19 which accounted for about 40% of all participants
in the meta-analysis and nearly 20% of all strokes,
resulted in a pooled relative risk of 1.19 (1.03 to 1.39),
P=0.022.
Salt intake and risk of cardiovascular disease
Table 2 provides data on the association between salt
intake and the risk of cardiovascular disease in 14
cohorts. In the pooled analysis, there was an associa-
tion between higher salt intake and risk of cardio-
vascular disease (1.14, 0.99 to 1.32; P=0.07) (fig 2).
The heterogeneity between studies was significant
(P<0.01; I
2=80%), but the funnel plot did not show
asymmetry, thus excluding publication bias (Egger’s
test: P=0.39; see appendix on bmj.com). The
Table 1 |Characteristics of prospective studies included in meta-analysis of studies on salt intake and stroke and cardiovascular disease (CVD)
Study Age (years) Sex No of people Outcome(s) Outcome assessment
Sodium intake
assessment
Study quality
score
Kagan, 1985, US
(Hawaii)
10
45-68 Men 7895 Total stroke Physical examination for residual of stroke at
baseline, 2 and 6 year follow-up; surveillance of
hospital discharges and death certificates reviewed
by neurologist
24h dietary recall 14
Hu, 1992, Taiwan
11 ≥36 Men and women 8562 Total stroke Casefindingthroughlocalhospitalreferralsandstudy
nurses. Certification by computed tomography
Household survey
questionnaire
12
Alderman, 1995, US,
occupational
6
52; 54 Men; women 1900; 1037 Total CVD,
total stroke
Review of hospital charts and death certificates (ICD-
9): CVD I410, I430-I434, I436-I438; stroke as above
without I410
24h urine
collection
12
Tunstall-Pedoe,
1997, Scotland
12
40-59 Men; women 5754; 5875 Total CVD Case notes requested for all hospital episodes of
myocardialinfarctionandotheremergencyadmission
for coronary heart disease, then extracted and coded
according to MONICA project criteria
24h urine
collection
15
He, 1999, US,
NHANES I
9
25-74 Men;women;non-
overweight;
overweight
3686; 5799;
6797; 2688
CVD death,
total stroke,
stroke death
Mortality based on death certificate reports. Incident
stroke based on death certificate reports in which
underlying cause of death was recorded with ICD-9
code(430-434.9,436or437.0-437.1)oroneormore
hospital stays with discharges with one of these
codes
24h dietary recall 17
Tuomilehto, 2001,
Finland
13
25-64 Men; women 1173; 1263 CVD death.
total stroke
National hospital discharge register ICD-8 and ICD-9,
430-438, and 390-448
24h urine
collection
18
Nagata, 2004,
Japan
14
≥35 Men; women 13 355; 15 724 Stroke death National vital statistics ICD-9 430-448 FFQ 18
Cohen, 2006, US,
NHANES II
15
30-74 Men and women 7154 CVD death,
stroke death
Mortality based on death certificate reports ICD-9
430-438
24h dietary recall 18
Geleijnse, 2007,
Netherlands
16
≥55 Men and women 1448 CVD death,
total stroke
GPs registries (ICD-10): I20-I25,I46,I49,I50,I60-I67,
I70-I74 and R96; I60-I67
FFQ and overnight
urine sodium
15
Cook, 2007, US,
TOHPI,USA,TOHPII
17
30-54; 30-54 Men and women;
men and women
542; 1873 Total CVD Notification of non-fatal outcomes in post-trial
surveillance,reviewbyphysician plusNationalDeath
Index
24h urine
collection
12
Larsson, 2008,
Finland
18
50-69 Men (smokers) 26,556 Total stroke Dischargediagnoses and death certificates (ICD-8, 9,
and 10)
FFQ 15
Umesawa, 2008,
Japan
19
40-79 Men; women 23 119; 35 611 CVD death,
stroke death
National Vital Statistics ICD-9 FFQ 4×3d a y
dietary records
18
Cohen, 2008, US,
NHANES III
20
≥30 Men and women 8699 Total CVD Vital status and cause of death (ICD-9 and ICD-10) 24h dietary recall 18
FFQ=food frequency questionnaire.
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towards a direct association between salt intake and
riskofcardiovasculardiseasein10cohorts,withsignif-
icantly higher relative risk in six. An inverse trend was
observed in four cohorts and was significant in one.
Sensitivity analysis showed that the exclusion of the
only study showing a significant inverse trend
6 led to
a pooled estimate of relative risk of 1.17 (1.02 to 1.34),
P=0.02 (fig 2). Further exclusion of the study by Ume-
sawa et al,
19 which accounted for over 50% of all parti-
cipants and about 40% of all cardiovascular disease
events led to a pooled relative risk of 1.14 (0.99 to
1.31), P=0.06.
Sources of heterogeneity
Age—Meta-regression analyses indicated no associa-
tion between mean age of study participants and effect
of sodium intake on the risk of stroke: exp(b)=1.01
(0.99 to 1.03). Likewise, meta-regression showed no
association between age and effect of sodium intake
on the risk of cardiovascular disease: exp(b)=0.99
(0.97 to 1.02).
Sex—Three studies reported data for men and
women separately for incidence of stroke.
61314 The
pooled estimates from these three studies were 1.30
(0.64 to 2.65; P=0.47) and 1.56 (1.14 to 2.13; P<0.01),
respectively. Three studies reported data for men and
women separately for incidence of cardiovascular
disease.
91213 The pooled estimates were 1.31 (0.97 to
1.77; P=0.08) and 1.27 (1.05 to 1.55; P=0.01), respec-
tively.
Method of assessment of sodium intake—In nine cohorts
that used food frequency questionnaires or dietary
recall for the evaluation of habitual sodium intake the
pooled risk estimate for stroke was 1.25 (1.03 to 1.51;
P=0.02).
10-1214151819 In five cohorts that used 24 hour
Table 2 |Detailed outcome of studies on salt intake and stroke and cardiovascular disease (CVD)
Study Comparison
All CVD All stroke
Factors controlled for in multivariate analysis Events RR (95% CI) Events RR (95% CI)
Kagan, 1985
10 Fifth (V v I) —— 238 0.92 (0.60 to 1.42) Age
Hu, 1992
11 Salty food (yes v no) —— 104 1.79 (1.18 to 2.70) Age
Alderman, 1995
6 Quarter (IV v I) in men 96 0.37 (0.18 to 0.75) 17 0.59 (0.10 to 3.43)
Unadjusted Alderman, 1995
6 Quarter (IV v I) in
women
21 2.29 (0.44 to 11.90) 6 2.10 (1.01 to 4.33)
Tunstall-Pedoe, 1997
12 Difference in men
between fifths
404 1.05 (0.97 to 1.14) ——
Age
Tunstall-Pedoe, 1997
12 Difference in women
between fifths
177 1.16 (1.01 to 1.33) ——
He, 1999
9 Continuous variable
(men, women)
895 1.67 (1.27 to 2.19),
1.54 (1.12 to 2.10)
——
Age, sex, race, SBP, cholesterol, BMI, diabetes,
diuretic use, education, alcohol, smoking, total
energy intake He, 1999
9 Continuous variable —— 430 overweight,
250 normal weight
0.99 (0.81 to 1.20),
1.39 (1.10 to 1.76)
Tuomilehto, 2001
13 Continuous variable
(men)
72 1.38 (1.05 to 1.81) 43 1.00 (0.68 to 1.48)
Age, study year, smoking, total cholesterol, HDL
cholesterol, SBP, BMI Tuomilehto, 2001
13 Continuous variable
(women)
15 1.43 (0.74 to 2.79) 41 1.34 (0.87 to 2.06)
Nagata, 2004
14 Thirds (III v I) in men —— 137 2.34 (1.23 to 4.47) Age, marital status, education, BMI, smoking,
alcohol,exercise,hypertension,diabetes,intake
of protein, total energy, vitamins K and E
Nagata, 2004
14 Thirds(IIIv I)inwomen —— 132 1.70 (0.96 to 3.00)
Cohen, 2006
15 Above v below median
sodium intake
541 0.88 (0.74 to 1.05) 79 0.56 (0.28 to 1.11) Age, sex, race, smoking, alcohol, SBP, BMI,
education, exercise, potassium and calories
intake, diabetes, cholesterol, anti-hypertensive
treatment.
Geleijnse, 2007
16 Continuous variable 217 0.77 (0.60 to 0.99) 181 1.08 (0.81 to 1.45) Age, sex, creatinine and potassium excretion,
BMI,smoking,diabetes,diureticuse,education,
energy intake, alcohol, calcium, saturated fat.
Cook I, 2007
17 Habitualvreducedsalt
intake
49 2.53 (1.30 to 4.94) ——
Age, race, sex, weigh loss, baseline weight,
sodium excretion Cook II, 2007
17 Habitualvreducedsalt
intake
151 1.12 (0.78 to 1.59) ——
Larsson, 2008
18 Fifths (V v I) —— 2702 1.04 (0.93 to 1.17) Age,supplementationgroup,smoking,BMI,SBP
and DBP, total cholesterol, HDL cholesterol,
diabetes, CHD, exercise, alcohol, energy intake
Umesawa, 2008
19 Fifth (V v I) 2087 1.42 (1.19 to 1.69) 986 1.55 (1.20 to 2.00) BMI, smoking, alcohol, hypertension, diabetes,
menopause, hormone therapy, exercise,
education, mental stress, calcium and
potassium intake
Cohen, 2008
20 Continuous variable 436 0.88 (0.77 to 1.01) —— Age, sex, race, education, added table salt,
exercise, alcohol, smoking, diabetes, cancer,
SBP,cholesterol,potassiumintake,weight,anti-
hypertensive treatment
SBP=systolic blood pressure, DBP=diastolic blood pressure, BMI=body mass index, HDL=high density lipoprotein, CHD=coronary heart disease.
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to1.44;P=0.17).
61316Infivecohortsthatusedfoodfre-
quencyquestionnairesordietaryrecallthepooledesti-
mate for cardiovascular disease was 1.21 (0.92 to 1.59;
P=0.17),
9151920 and in nine cohorts that used 24 hour
urine collection the pooled risk estimate for cardio-
vascular disease was 1.10 (0.92 to 1.31; P=
0.32).
612131617
Baselinebloodpressureorhypertensionstatus—Inthestu-
dies that provided relative risk estimates adjusted for
baseline blood pressure or hypertension status, the
pooled relative risk was 1.22 (1.02 to 1.45; P=0.03)
for stroke (nine cohorts) and 1.25 (0.99 to 1.57;
P=0.06) for cardiovascular disease (seven cohorts).
Baseline body mass index (BMI) or body weight—In the
studies that provided relative risk estimates adjusted
for baseline BMI or body weight, the pooled relative
risk was 1.20 (1.02 to 1.40; P=0.02) for stroke (10
cohorts) and 1.22 (1.00 to 1.49; P=0.05) for cardio-
vascular disease (10 cohorts).
Length of follow-up—Meta-regression analysis
showed a significant association between duration of
follow-upandtheeffectofsodiumontheriskofstroke.
The log relative risk was estimated to increase by 0.07
per increase of one year of follow-up: exp(b)=1.07
(1.04 to 1.10). The estimated variance between studies
(heterogeneity) was reduced from 0.05 to 0.02. In con-
trast, however, we found no association between dura-
tion of follow-up and effect of sodium on the risk of
cardiovascular disease: exp(b)=0.98 (0.95 to 1.02).
Dose-response analysis—Variance weighted least
squares regression of the risk of stroke on the study
specific difference between higher and lower cate-
gories of sodium intake (differences in sodium intake
values reported in table 2) provided evidence of a sig-
nificant direct association (exp(b)=1.06 (1.03 to 1.10)),
indicating a 6% increase in the rate of stroke for every
50mmol/daydifferenceinsodiumintake.Therewasa
similartrendfortheriskofcardiovasculardisease(exp
(b)=1.19 (0.69 to 2.07)), that was not significant.
Time trend (year of publication)—Starting with the first
publishedstudy
10wecalculatedthecumulativepooled
relative risk by stepwise addition of the results of the
other available studies up to the last one published in
July 2008.
19 Figure 3 shows the results of these cumu-
lative meta-analyses. The pooled relative risk for
stroke stabilised early in the 1.20-1.30 interval and
achieved significance starting in 2001. Similar results
wereobtainedintheanalysisofcardiovasculardisease,
for which the pooled relative risk estimate also stabi-
lisedearlyandclosetothefinalvalue,achievingsignif-
icance starting in 1999.
DISCUSSION
This meta-analysis shows unequivocally that higher
salt intake is associated with a greater incidence of
strokesandtotalcardiovascularevents.Oursystematic
review identified 13 relevant and suitable studies pub-
lished from 1996 to 2008. These studies provided evi-
dence from 170000 people contributing overall more
than 10000 vascular events.
Cardiovasculardiseasesarethemajorcauseofdeath
among people aged over 60 and second among those
aged 15-59. According to the World Health
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Fig 1 | Risk of incident stroke associated with higher compared with lower salt intake in 14 population cohorts from 10
published prospective studies including 154282 participants and 5346 events
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heart disease events are attributable to high blood
pressure.
27 The direct causal relation between levels
of dietary salt intake and blood pressure at the popula-
tion level has also been recognised.
12829 Given the
graded causal relation between blood pressure and
cardiovascular disease, beginning at around 115 mm
Hg systolic pressure,
30 it is reasonable to expect con-
siderable benefit on the rate of cardiovascular disease
from a reduction in salt intake.
Association between salt intake, stroke, and cardiovascular
disease
The results of this meta-analysis provide evidence of a
direct association between high dietary salt intake and
risk of stroke. Despite the considerable heterogeneity
between the 14 cohorts available for the analysis, the
results are strengthened by the lack of major publica-
tionbiasandbytheobservationofasignificantassocia-
tioninfourindividualcohortsincludedintheanalysis,
whereas in none was an inverse statistical association
apparent. The pooled relative risk indicates a 23%
greater risk of stroke for an average difference in
sodium intake (weighted for the population size of
each study) of 86 mmol (equivalent to about 5 g of
salt a day). Sensitivity analysis with the exclusion of a
single study, on the basis of its particular weight with
regardtobothnumberofparticipantsandevents,only
moderatelyreducedthedifferenceinrisk(from23%to
19%), which remained significant.
Likewise, the pooled analysis of the 12 cohorts for
which data on cardiovascular disease outcome were
available(aftertheexclusionofasingleoutlier)showed
a direct association between higher salt intake and risk
ofcardiovasculardisease,witha pooledrelativerisk of
1.17.
4 A trend in this direction occurred in as many as
nine of the 12 cohorts and was significant in six. There
was an inverse trend in three cohorts.
151620 The study
by Alderman et al,
6 showing a relative risk in men of
0.37, has been challenged because of the low number
of events recorded and several methodological inade-
quacies, the most important being the evaluation of
habitual salt consumption on the basis of 24 hour
urine collection obtained shortly after the study parti-
cipants had been instructed to reduce their usual level
of sodium intake.
31 The results of sensitivity analysis
indicate that the exclusion of this single study from
our meta-analysis strengthens the estimate. The addi-
tional exclusion of a large Japanese cohort providing a
high proportion of participants and events overall
19
only slightly reduced the pooled relative risk estimate
(from 1.17 to 1.14) and the level of significance (to
0.06).
Evaluation of main sources of heterogeneity
We used subgroup and meta-regression analyses to
assesstheinfluenceofseveralfactorsontheassociation
between habitual sodium intake and risk of stroke or
cardiovascular disease. For both stroke and cardio-
vascular disease outcomes, separate analyses of the
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Fig 2 | Risk of incident cardiovascular disease associated with higher compared with lower salt intake in 14 population cohorts
from nine published prospective studies including 104132 participants and 5161 events. Pooled analysis after the exclusion
of the study by Alderman et al
6 (men and women), including 102086 participants and 5044 events
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are consistent and not significantly different between
the sexes. Similar results were obtained with respect
to the method of assessment of habitual sodium intake
used in the various studies.
Eight studies provided data adjusted for baseline
blood pressure or hypertension status. Separate eva-
luations of these studies provided relative risk esti-
mates for both stroke and cardiovascular disease
similartothoseobtainedforthetotalnumberofstudies
included in the meta-analysis. This finding seems at
variance with the hypothesis that the effect of salt on
cardiovascular risk is substantially mediated by its
unfavourable action on blood pressure. Adjustment
for baseline blood pressure or hypertension status
only partially corrects for the overall influence of
blood pressure on the study results in as much as it
does not account for changes in blood pressure occur-
ring during the observation period, a problem more
relevant the longer the follow-up period. Part of the
association observed, however, might be mediated by
factorsotherthanbloodpressure,andthereisevidence
inthe literatureofdeleteriouseffectsofhighsalt intake
on left ventricular mass,
32-34 arterial stiffness,
35 and
renal function,
3637 which are not totally explained by
its effect on blood pressure.
Overweight and obesity are often associated with
high blood pressure and are causally involved in the
development of hypertension.
38 Nine out of 13 studies
included in the meta-analysis provided relative risk
estimates adjusted for BMI or body weight at entry
into the study.
914-21 Therefore, as for blood pressure,
the association between habitual sodium intake and
risk of stroke and cardiovascular disease seems partly
independentfromtheinfluenceofexcessbodyweight.
Two studies, however, reported a significant inter-
actionbetweenoverweightandhabitualsodiumintake
on the risk of cardiovascular events.
913This finding is
consistent with the description of alterations in renal
tubular sodium handling in obese individuals, making
them particularly sensitive to the effects of high salt
intake.
39
Study limitations
Thestudiesincludedinourmeta-analysiswerehetero-
geneous regarding sample size, number of events, and
duration of follow-up, with a few cohorts having small
numbers. In the calculation of the pooled relative risk
we weighted the results of the individual studies for
sample size but did not account for the duration of fol-
low-up. Our meta-regression analysis indicated that
the longer the follow-up the greater the effect of habi-
tual sodium intake on the risk of stroke but not, appar-
ently, on the risk of total cardiovascular events.
Possible explanations for this discrepancy are the
higher mean age at occurrence of stroke, which
would increase the chances of an event the longer the
follow-up, and the closer relation of high blood pres-
sure to stroke compared with other types of vascular
events.
Theestimateofthebaselinepopulationsaltintakein
each study was based on a single measurement
(whether through 24 hour urine collection or dietary
assessment). We were therefore unable to correct for
regressiondilutionbias.Becauseofthelargedaytoday
variability within people in salt consumption and the
consequentdilutingeffectimposedontheaverageesti-
mate of exposure, our estimates of risk are probably
underestimated.
Categorisationofsaltintakewasalsoheterogeneous:
some studies stratified the population by categories of
sodiumintakeandcomparedcardiovascularoutcomes
across categories, other studies gave a difference in
outcome for a given difference (for example,
100 mmol/24 h) in sodium intake or excretion. To
standardise our comparison between higher and
lower salt consumption we sought to refer to a differ-
ence as close as possible to 100 mmol or 6 g a day
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Fig 3 | Cumulative meta-analysis. Evaluation of time trends
(year of publication) in relation between habitual sodium
intake and risk of stroke or cardiovascular disease
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remained appreciable differences in this respect
between studies. We tried to overcome the problem
with meta-regression analysis, which provided evi-
dence of a highly significant dose-response relation
between the difference in sodium intake and the
increase in risk of both stroke and cardiovascular dis-
ease.
Implications
The habitual salt intake in most Western countries is
close to 10 g a day (and much higher in many Eastern
Europeanand Asiancountries),andwe calculatedthat
the average difference between higher and lower salt
intake across the study cohorts included in our meta-
analysiswas5gaday.Giventhisapproach,webelieve
that, despite the inherent inaccuracies, the results of
ourmeta-analysisare applicable to reallifeconditions.
A reduction of 5 g (about one teaspoon) of salt would
bring consumption close to the WHO recommended
level (5 g a day at the population level).
AccordingtoarecentreportoftheWorldHeartFed-
eration there are over 5.5 million deaths a year from
stroke throughout the world and close to 17.5 million
deathsayearfromcardiovasculardisease.
40Giventhat
the case fatality rates for stroke is estimated at one in
three and those for total cardiovascular disease at one
in five, a 23% reduction in the rate of stroke and a 17%
overall reduction in the rate of cardiovascular disease
attributable to a reduction in population salt intake
could avert some one and a quarter million deaths
from stroke and almost three million deaths from
cardiovascular disease each year. Many studies have
also shown that a reduction in salt intake is cost
effective,
41-43 arguing for the more widespread intro-
duction of national programmes to reduce dietary salt
consumption. In recent years, a few countries have
made some progress towards reduction of habitual
saltintakethroughavoluntaryapproach
1orbyregula-
tion, as in Finland,
42 but levels of salt consumption are
still far from the WHO recommended targets. There
are many reasons for these delays. One barrier to a
more effective implementation of public health poli-
cies has been the historical opposition of the food
industry,
44 based on the arguments that the available
evidence does not show significant benefits on hard
end points at a population level from a moderate
reduction in salt intake. Our study now clearly
addresses those doubts. Some progress has been
made in the past few years by closer collaboration
between governments, public health bodies, and
some sectors of the industry on a “voluntary” basis, as
in the UK, with the reformulation of many food items
towardsalowersaltcontentandproposalsofimproved
labelling.Theseeffortshaveledtoareductionof0.9ga
day (or about 10%) in population salt intake in four
years (from 9.5 to 8.6 g a day), still far from the recom-
mended6gadayinitialtargetsthatweresetintheUK.
While the voluntary approach is the preferred choice
for many governments, the “regulatory” approach has
advantages,
45 sometimes being the most efficient,
effective, and cost effective way of achieving public
health targets.
41-43 For population salt intake to
approach the recommended targets within a reason-
abletimeframe,an“upstream”approachisnowneces-
sary alongside the traditional “downstream” public
health approachbased on healthpromotion and beha-
vioural changes.
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